Total Payments
$3,684
2024 Payments
$1,260
Companies
29
Transactions
171
Medicare Patients
1,299
Medicare Billing
$193,342
Payment Breakdown by Category
Food & Beverage$3,684 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,684 | 171 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $796.80 | 42 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $657.85 | 35 | $0 (2024) |
| Gilead Sciences, Inc. | $387.90 | 19 | $0 (2024) |
| Celgene Corporation | $268.81 | 16 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $268.79 | 11 | $0 (2024) |
| Inari Medical, Inc. | $166.50 | 1 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $141.57 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $115.68 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $102.80 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $100.04 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,260 | 46 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($240.99) |
| 2023 | $772.85 | 44 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($212.93) |
| 2022 | $618.68 | 33 | ABBVIE INC. ($135.73) |
| 2021 | $406.71 | 21 | AbbVie Inc. ($127.32) |
| 2020 | $429.63 | 18 | Intercept Pharmaceuticals, Inc. ($104.31) |
| 2019 | $155.78 | 7 | Gilead Sciences, Inc. ($44.16) |
| 2017 | $40.19 | 2 | Janssen Biotech, Inc. ($20.26) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: LIVER DISEASE | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.11 | General |
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: VIROLOGY | ||||||
| 08/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.44 | General |
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Gastroenterology | ||||||
| 07/24/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/09/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Gastroenterology | ||||||
| 06/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Gastroenterology | ||||||
| 06/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Gastroenterology | ||||||
| 05/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 257 | 691 | $81,196 | $30,996 |
| 2022 | 9 | 284 | 1,072 | $94,768 | $28,396 |
| 2021 | 10 | 294 | 1,602 | $80,873 | $25,481 |
| 2020 | 7 | 464 | 1,110 | $282,223 | $108,468 |
Total Patients
1,299
Total Services
4,475
Medicare Billing
$193,342
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 193 | $44,484 | $18,814 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $17,748 | $5,901 | 33.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $8,172 | $3,054 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 21 | $3,318 | $1,115 | 33.6% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 11 | 11 | $2,805 | $1,037 | 37.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 16 | 17 | $3,400 | $691.56 | 20.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 21 | $1,008 | $351.91 | 34.9% |
| J2704 | Injection, propofol, 10 mg | Office | 2023 | 15 | 341 | $260.50 | $31.99 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 93 | $21,324 | $8,862 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 38 | 64 | $26,303 | $4,917 | 18.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 13 | 13 | $10,231 | $3,837 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $10,788 | $3,806 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 45 | $7,248 | $2,933 | 40.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $7,264 | $2,399 | 33.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2022 | 24 | 26 | $5,200 | $1,098 | 21.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 17 | 20 | $960.00 | $301.29 | 31.4% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2022 | 14 | 18 | $1,800 | $166.29 | 9.2% |
| J2704 | Injection, propofol, 10 mg | Office | 2022 | 24 | 730 | $3,650 | $75.85 | 2.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 74 | $16,992 | $7,069 | 41.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $16,356 | $5,764 | 35.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 18 | 18 | $14,166 | $4,911 | 34.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 53 | $8,374 | $3,969 | 47.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $3,859 | $1,514 | 39.2% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Office | 2021 | 34 | 34 | $6,523 | $1,450 | 22.2% |
| 99153 | Moderate sedation services by physician also performing a procedure, additional 15 minutes | Office | 2021 | 28 | 43 | $4,300 | $382.85 | 8.9% |
About Dr. John Rivas, MD
Dr. John Rivas, MD is a Gastroenterology healthcare provider based in Fort Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1831412360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Rivas, MD has received a total of $3,684 in payments from pharmaceutical and medical device companies, with $1,260 received in 2024. These payments were reported across 171 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,684).
As a Medicare-enrolled provider, Rivas has provided services to 1,299 Medicare beneficiaries, totaling 4,475 services with total Medicare billing of $193,342. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Transplant Hepatology
- Location Fort Lauderdale, FL
- Active Since 03/11/2010
- Last Updated 11/14/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1831412360
Products in Payments
- XIFAXAN (Drug) $596.42
- RINVOQ (Biological) $323.50
- ZEPOSIA (Drug) $254.12
- OCALIVA (Drug) $239.47
- FLOWTRIEVER CATHETER, S (Device) $166.50
- UPTRAVI (Drug) $141.57
- MAVYRET (Drug) $132.50
- HUMIRA (Biological) $103.74
- VOQUEZNA (Drug) $96.49
- STELARA (Biological) $89.60
- DIFICID (Drug) $82.87
- SUTAB (Drug) $62.67
- TRULANCE (Drug) $61.43
- ENTYVIO (Biological) $54.52
- VEGZELMA (Biological) $52.66
- SKYRIZI (Biological) $49.58
- DUPIXENT (Biological) $49.08
- GATTEX (Drug) $45.52
- Mavyret (Drug) $43.97
- TERLIVAZ (Drug) $38.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Lauderdale
Dr. Charles Hotte, M.d, M.D
Gastroenterology — Payments: $10,087
Gastroenterology $10,087
Dr. Edwin Golikov, D.o, D.O
Gastroenterology — Payments: $9,138
Gastroenterology $9,138
Dr. Daniel Kosches, M.d, M.D
Gastroenterology — Payments: $6,835
Gastroenterology $6,835
Dr. Manuel Babaian, Md, MD
Gastroenterology — Payments: $6,393
Gastroenterology $6,393
Dr. Paul Feldman, M.d, M.D
Gastroenterology — Payments: $927.27
Gastroenterology $927.27
Vlaicu Botoman, Md, MD
Gastroenterology — Payments: $733.23
Gastroenterology $733.23